A Study to Assess Change in Disease Activity in Adolescents and Adults With Moderate to Severe Prurigo-type Atopic Dermatitis in Japan Who Are Treated With Oral Upadacitinib
RecruitingOBSERVATIONAL
Enrollment
200
Participants
Timeline
Start Date
December 8, 2022
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Conditions
Atopic Dermatitis
Trial Locations (1)
983-0005
RECRUITING
Tohoku Medical and Pharmaceuti /ID# 252486, Sendai